Aytu BioPharma, Inc. (NASDAQ:AYTU) Q3 2023 Earnings Call Transcript May 11, 2023
Aytu BioPharma, Inc. misses on earnings expectations. Reported EPS is $-1.93 EPS, expectations were $-0.63.
Operator: Greetings. Welcome to the Aytu BioPharma Fiscal 2023 Q3 Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note this conference is being recorded. I’ll now turn the conference over to your host, Roger Weiss. You may begin.
Roger...
